Cargando…
PET/MRI enables simultaneous in vivo quantification of β-cell mass and function
Non-invasive imaging of β-cells represents a desirable preclinical and clinical tool to monitor the change of β-cell mass and the loss of function during pre-diabetic stages. Although it is widely accepted that manganese (Mn) ions are actively gated by voltage-dependent calcium channels (VDCC) in re...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929626/ https://www.ncbi.nlm.nih.gov/pubmed/31903128 http://dx.doi.org/10.7150/thno.33410 |
_version_ | 1783482739030228992 |
---|---|
author | Michelotti, Filippo C. Bowden, Gregory Küppers, Astrid Joosten, Lieke Maczewsky, Jonas Nischwitz, Volker Drews, Gisela Maurer, Andreas Gotthardt, Martin Schmid, Andreas M. Pichler, Bernd J. |
author_facet | Michelotti, Filippo C. Bowden, Gregory Küppers, Astrid Joosten, Lieke Maczewsky, Jonas Nischwitz, Volker Drews, Gisela Maurer, Andreas Gotthardt, Martin Schmid, Andreas M. Pichler, Bernd J. |
author_sort | Michelotti, Filippo C. |
collection | PubMed |
description | Non-invasive imaging of β-cells represents a desirable preclinical and clinical tool to monitor the change of β-cell mass and the loss of function during pre-diabetic stages. Although it is widely accepted that manganese (Mn) ions are actively gated by voltage-dependent calcium channels (VDCC) in response to glucose metabolism, little is known on its specificity in vivo for quantification of islet β-cell function using Mn and magnetic resonance imaging (MRI). On the other hand, glucagon-like-peptide-1 receptor (GLP-1R) represents a validated target for the estimation of β-cell mass using radiolabeled exendin-4 (Ex4) and positron emission tomography (PET). However, a multiparametric imaging workflow revealing β-cell mass and function quantitatively is still missing. Methods: We developed a simultaneous PET/MRI protocol to comprehensively quantify in vivo changes in β-cell mass and function by targeting, respectively, GLP-1R and VDCC coupled with insulin secretion. Differences in the spatial distribution of Mn and radiolabeled Ex4 were monitored overtime in native and transgenic pancreata, characterized by spontaneous pancreatic neuroendocrine tumor development. Follow-up with mass spectrometry imaging (MSI) and autoradiography allowed the ex vivo validation of the specificity of Mn and PET tracer uptake and the detection of endogenous biometals, such as calcium and zinc, throughout the endocrine and exocrine pancreas. Results: Our in vivo data based on a volumetric PET/MRI readout for native pancreata and insulinomas connects uptake of Mn measured at early imaging time points to high non-specific binding by the exocrine tissue, while specific retention was only found 24 h post injection. These results are supported by cross-validation of the spatial distribution of exogenous (55)Mn and endogenous (44)Ca and (64)Zn as well with the specific internalization of the radiolabeled peptide targeting GLP-1R. Conclusion: Simultaneous PET/MR imaging of the pancreas enabled the comprehensive in vivo quantification of β-cell function and mass using Mn and radiolabeled Ex4. Most important, our data revealed that only late time-point measurements reflect the Mn uptake in the islet β-cells, while early time points detect non-specific accumulation of Mn in the exocrine pancreas. |
format | Online Article Text |
id | pubmed-6929626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-69296262020-01-04 PET/MRI enables simultaneous in vivo quantification of β-cell mass and function Michelotti, Filippo C. Bowden, Gregory Küppers, Astrid Joosten, Lieke Maczewsky, Jonas Nischwitz, Volker Drews, Gisela Maurer, Andreas Gotthardt, Martin Schmid, Andreas M. Pichler, Bernd J. Theranostics Research Paper Non-invasive imaging of β-cells represents a desirable preclinical and clinical tool to monitor the change of β-cell mass and the loss of function during pre-diabetic stages. Although it is widely accepted that manganese (Mn) ions are actively gated by voltage-dependent calcium channels (VDCC) in response to glucose metabolism, little is known on its specificity in vivo for quantification of islet β-cell function using Mn and magnetic resonance imaging (MRI). On the other hand, glucagon-like-peptide-1 receptor (GLP-1R) represents a validated target for the estimation of β-cell mass using radiolabeled exendin-4 (Ex4) and positron emission tomography (PET). However, a multiparametric imaging workflow revealing β-cell mass and function quantitatively is still missing. Methods: We developed a simultaneous PET/MRI protocol to comprehensively quantify in vivo changes in β-cell mass and function by targeting, respectively, GLP-1R and VDCC coupled with insulin secretion. Differences in the spatial distribution of Mn and radiolabeled Ex4 were monitored overtime in native and transgenic pancreata, characterized by spontaneous pancreatic neuroendocrine tumor development. Follow-up with mass spectrometry imaging (MSI) and autoradiography allowed the ex vivo validation of the specificity of Mn and PET tracer uptake and the detection of endogenous biometals, such as calcium and zinc, throughout the endocrine and exocrine pancreas. Results: Our in vivo data based on a volumetric PET/MRI readout for native pancreata and insulinomas connects uptake of Mn measured at early imaging time points to high non-specific binding by the exocrine tissue, while specific retention was only found 24 h post injection. These results are supported by cross-validation of the spatial distribution of exogenous (55)Mn and endogenous (44)Ca and (64)Zn as well with the specific internalization of the radiolabeled peptide targeting GLP-1R. Conclusion: Simultaneous PET/MR imaging of the pancreas enabled the comprehensive in vivo quantification of β-cell function and mass using Mn and radiolabeled Ex4. Most important, our data revealed that only late time-point measurements reflect the Mn uptake in the islet β-cells, while early time points detect non-specific accumulation of Mn in the exocrine pancreas. Ivyspring International Publisher 2020-01-01 /pmc/articles/PMC6929626/ /pubmed/31903128 http://dx.doi.org/10.7150/thno.33410 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Michelotti, Filippo C. Bowden, Gregory Küppers, Astrid Joosten, Lieke Maczewsky, Jonas Nischwitz, Volker Drews, Gisela Maurer, Andreas Gotthardt, Martin Schmid, Andreas M. Pichler, Bernd J. PET/MRI enables simultaneous in vivo quantification of β-cell mass and function |
title | PET/MRI enables simultaneous in vivo quantification of β-cell mass and function |
title_full | PET/MRI enables simultaneous in vivo quantification of β-cell mass and function |
title_fullStr | PET/MRI enables simultaneous in vivo quantification of β-cell mass and function |
title_full_unstemmed | PET/MRI enables simultaneous in vivo quantification of β-cell mass and function |
title_short | PET/MRI enables simultaneous in vivo quantification of β-cell mass and function |
title_sort | pet/mri enables simultaneous in vivo quantification of β-cell mass and function |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929626/ https://www.ncbi.nlm.nih.gov/pubmed/31903128 http://dx.doi.org/10.7150/thno.33410 |
work_keys_str_mv | AT michelottifilippoc petmrienablessimultaneousinvivoquantificationofbcellmassandfunction AT bowdengregory petmrienablessimultaneousinvivoquantificationofbcellmassandfunction AT kuppersastrid petmrienablessimultaneousinvivoquantificationofbcellmassandfunction AT joostenlieke petmrienablessimultaneousinvivoquantificationofbcellmassandfunction AT maczewskyjonas petmrienablessimultaneousinvivoquantificationofbcellmassandfunction AT nischwitzvolker petmrienablessimultaneousinvivoquantificationofbcellmassandfunction AT drewsgisela petmrienablessimultaneousinvivoquantificationofbcellmassandfunction AT maurerandreas petmrienablessimultaneousinvivoquantificationofbcellmassandfunction AT gotthardtmartin petmrienablessimultaneousinvivoquantificationofbcellmassandfunction AT schmidandreasm petmrienablessimultaneousinvivoquantificationofbcellmassandfunction AT pichlerberndj petmrienablessimultaneousinvivoquantificationofbcellmassandfunction |